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The microtubule-binding 63-kDa cytoskeleton-linking membrane protein (CLIMP-63) is an integral membrane protein
that links the endoplasmic reticulum (ER) to microtubules. Here, we tested whether this interaction is regulated by
phosphorylation. Metabolic labeling with 32P showed that CLIMP-63 is a phosphoprotein with increased phosphorylation
during mitosis. CLIMP-63 of mitotic cells is unable to bind to microtubules in vitro. Mitotic phosphorylation can be
prevented by mutation of serines 3, 17, and 19 in the cytoplasmic domain of CLIMP-63. When these residues are mutated
to glutamic acid, and hence mimic mitotic phosphorylation, CLIMP-63 does no longer bind to microtubules in vitro.
Overexpression of the phospho-mimicking mitotic form of CLIMP-63 in interphase cells leads to a collapse of the ER
around the nucleus, leaving the microtubular network intact. The results suggest that CLIMP-63–mediated stable
anchoring of the ER to microtubules is required to maintain the spatial distribution of the ER during interphase and that
this interaction is abolished by phosphorylation of CLIMP-63 during mitosis.
INTRODUCTION
The endoplasmic reticulum (ER) of animal cells is a contin-
uous network of membranes connected to the nuclear enve-
lope. In most cell types, it extends into the entire cytoplasm
as interconnected tubules that form a characteristic polygo-
nal structure characterized by three-way junctions (Terasaki
et al., 1986; Lee and Chen, 1988; Dailey and Bridgman, 1989).
Studies in living cells showed that the ER is highly dynamic
with numerous elongation, fusion, and junction sliding
events occurring within the existing network (Lee and Chen,
1988). These dynamics are supported by microtubules
(MTs). ER tubules often coalign with individual MTs, and
the use of MT-depolymerizing drugs showed that the for-
mation of ER tubules correlates with MT assembly (Terasaki
et al., 1986; Lee et al., 1989; Waterman-Storer and Salmon,
1998). In migrating cells, ER tubules are pulled out by MT tip
polymerization or extend toward the plus end of MTs (Wa-
terman-Storer and Salmon, 1998), a movement known to be
powered by members of the kinesin motor family (Hiro-
kawa, 1998). Kinesins bind to cargo membranes either via
transmembrane receptors that may or may not involve cy-
toplasmic linkers (Kamal and Goldstein, 2002) or via phos-
pholipids (Klopfenstein et al., 2002). MT minus end-directed
transport of membranes, mediated by cytoplasmic dyneins,
is mainly involved in the positioning of endosomes, lyso-
somes, and the Golgi apparatus (Goodson et al., 1997; Hiro-
kawa, 1998). Dynein-based movement of ER membranes
also has been observed in some cases but seems to occur less
frequently (Allan, 1995; Lane and Allan, 1999; Wedlich-
Soldner et al., 2002).
The 63-kDa cytoskeleton-linking membrane protein
(CLIMP-63) is a nonglycosylated type II ER membrane pro-
tein that is excluded from the nuclear envelope (Schweizer et
al., 1993a). Restricted localization of CLIMP-63 to the retic-
ular part of the ER is mediated by self-association that
retains the protein in the ER (Schweizer et al., 1994) and
limits its mobility in the membrane (Klopfenstein et al.,
2001). The cytoplasmic segment of CLIMP-63 binds to MTs,
both in vivo and in vitro, and overexpression of the protein
leads to a parallel rearrangement of ER and MTs, suggesting
that the protein links ER membranes to the MT cytoskeleton
(Klopfenstein et al., 1998). Other nonmotor proteins linking
membranes to MTs have been described, but these are sol-
uble proteins. They include the peripheral Golgi proteins
GMAP-210 (Infante et al., 1999) and Hook 3 (Walenta et al.,
2001), both proposed to participate in Golgi architecture and
anchoring to the minus end of MTs, and MT plus end-
binding proteins of the cytoplasmic linker protein (CLIP)
family (Galjart and Perez, 2003). Compared with these MT-
binding proteins, CLIMP-63 is unique in that it 1) is a mem-
brane protein, 2) mediates direct interaction between ER
membranes and MTs via its cytoplasmic MT-binding do-
main, and 3) links membranes along the entire length of
MTs.
In higher eukaryotes, MTs that are centrosome-nucleated
during interphase undergo dramatic rearrangements into
the mitotic spindle during cell division. Concomitantly,
membrane traffic is inhibited (Warren, 1993). Recent fluores-
cence photobleaching experiments suggest that ER mem-
branes during mitosis are continuous rather than vesicu-
lated as previously thought (Ellenberg et al., 1997; Yang et al.,
1997; Terasaki, 2000). In Drosophila and sea urchin embryos,
the ER accumulates at the mitotic poles (Terasaki, 2000;
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Bobinnec et al., 2003). If CLIMP-63 stably anchors ER mem-
branes to MTs during interphase, it is conceivable that this
interaction is abolished during mitosis. Protein binding to
MTs, as studied for MT-associated proteins (MAPs), is reg-
ulated by phosphorylation that influences mainly negatively
the interaction with MTs. Phosphorylation decreases MT
affinity of tau proteins (Drewes et al., 1995; Cho and Johnson,
2003; Hamdane et al., 2003), neuronal MAP2, and ubiquitous
MAP4 (Illenberger et al., 1996; Ozer and Halpain, 2000; Al-
exa et al., 2002). Inhibition of specific MAP functions, such as
MT polymerization or MT nucleation-promoting activities,
also have been reported (Leger et al., 1997; Kitazawa et al.,
2000; Amano et al., 2003). The phosphorylation of nonneu-
ronal MAPs is believed to increase MT dynamics during
mitosis (Masson and Kreis, 1995; Ookata et al., 1995; Shiina
and Tsukita, 1999). In the present study, we have investi-




Phospho-mimicking mutants were constructed by standard overlapping
polymerase chain reaction (PCR) techniques. For single mutants, complemen-
tary primers carrying the desired mutation were coupled to upstream (match-
ing vector sequence, 5-gag ctc gga tcc act agt aac-3) or downstream (match-
ing CLIMP-63 coding sequence, 5-cca cat gga tcc cat ccg ag-3) primers in PCR
by using pcDNA3-p63 plasmid (Klopfenstein et al., 1998) as a template.
Amplified overlapping DNA fragments were mixed in a 1:1 ratio and used as
template in a second PCR with external primers. The resulting PCR product
was digested with BamHI and used to replace the corresponding restriction
fragment into pcDNA3-p63 initial plasmid. Double, triple, and quadruple
phospho-mimicking mutants were constructed by sequentially adding point
mutations by using the same strategy described above. CLIMP-63 was
constructed by PCR amplification in two sequential steps. Amino acids 2–28
were deleted in pcDNA3-p63 by replacing the EcoRI/NotI fragment repre-
senting amino acids 1–118 with the correspondingly digested PCR fragment
encoding the start methionine followed by amino acids 29–118 (upstream
oligo, 5-gaa ttc atg gcg gat gac gtg gcg aag aag-3; downstream oligo, 5-agc
ggc cgc cgc cac cag ggc gag g-3). Deletion of amino acids 62–101 was created
by replacing the EcoRI/NotI fragment in pcDNA3-p63 with a PCR fragment
corresponding to amino acids 1–61 fused to 102–118 (upstream oligo, 5-gaa
ttc atg ccc tcg gcc aaa caa ag-3; downstream oligo, 5-agc ggc cgc cgc cac cag
ggc gag gta gaa gag aaa gtt gag cgc cct ggc gag cct gcg gtt ctg cgg gtg ctg ctg
c-3). Next, the SgrAI restriction site encompassing the corresponding amino
acids 37–39 was used to combine the two deletion regions into a single
construct: SgrAI/NotI DNA fragment from the (62–101) construct was ex-
changed with the corresponding fragment into the (2–28) construct, giving
rise to CLIMP-63. For CLIMP-63* constructs, the C-terminal part of
CLIMP-63 was PCR amplified using a primer that introduces a stop codon in
place of N538 (5 ctt ctc tag act aac tga aag 3) and a downstream primer
matching pcDNA3 vector sequence (5 ccc tct aga tgc atg ctc 3). Resulting
DNA fragment was digested with XbaI and exchanged with its counterpart in
the adequate plasmids to create the short versions of CLIMP-63, CLIMP-63
and all triple and quadruple phospho-mimicking mutants.
Cell Culture and Transfection
COS cells were maintained in DMEM containing 10% fetal calf serum, 100
U/ml penicillin, 100 g/ml streptomycin, and 1 g/ml fungizone. HeLa cells
were cultured identically, except that the medium was supplemented with
nonessential amino acids. COS cells were transiently transfected using the
DEAE-dextran method (Cullen, 1987). HeLa cells were transfected using
FuGene 6 reagent (Roche Diagnostics, Mannheim, Germany) according to
manufacturer’s instructions. To obtain stable clones, cells were diluted into
96-wells plates (100 cells/well) 24 h posttransfection and selected in the
presence of 0.7 mg/ml Geneticin (G418).
Microtubule-binding Assays
Forty-eight hours posttransfection, transfected or nontransfected COS cells of
a 60-mm dish were washed twice with ice-cold phosphate-buffered saline
(PBS), scraped, and collected by centrifugation for 10 min at 750  g at 4°C.
Cell pellets were solubilized for 1 h at 4°C in 1 ml of PNT buffer (20 mM
PIPES, 30 mM Tris, 100 mM NaCl, 1 mM EGTA, 1.25 mM EDTA, pH 7.0)
containing 1% Triton X-100, protease inhibitors, and 100 mM iodoacetamide,
and centrifuged for 1 h at 20,000  g at 4°C. For MT binding, 50 g of
taxol-stabilized MTs (Brugg and Matus, 1991) was resuspended in 100 l of
cleared lysate and incubated for 30 min at 37°C. Samples were then centri-
fuged for 10 min at 230,000  g at 25°C, and supernatant and pellet were
analyzed by SDS-PAGE and Western blotting for the presence of tubulin and
CLIMP-63. Mitotic cells were enriched by 18-h incubation with 100 nM
nocodazole.
Immunofluorescence Microscopy
COS cells were plated on Lab-Tek multiwell glass slides (Nalge Nunc, Na-
perville, IL) the day before transfection. After 48 h, the cells were fixed for 30
min with 3% paraformaldehyde in PBS, permeabilized with 0.1% saponin in
PBS, and processed for immunofluorescence microscopy. Cells were imaged
in Mowiol mounting medium with a 63 objective (1.32 numerical aperture)
by using a Leica TCS NT confocal laser scanning microscope. Bleed-through
in double-labeling experiments was avoided by sequential image acquire-
ment and tested in single-labeling experiments.
Antibodies
The following primary antibodies were used: mouse monoclonal antibody
(mAb) G1/296 (an IgG2a) (Schweizer et al., 1993a), mouse mAb A1/59 (an
IgG1), a rabbit polyclonal antibody against CLIMP-63, mouse mAb 1A2 (an
IgG3) against -tubulin (kindly provided by Karl Matter, University College
London, United Kingdom), mouse mAb A1/182 (an IgG2a) against BAP31
(Klumperman et al., 1998), and rabbit IgG against phosphorylated serine 10 of
histone 3 (Upstate Biotechnology, Lake Placid, NY). mAb A1/59 was pro-
duced by the hybridoma technique (Schweizer et al., 1988) by using a mem-
brane fraction of Vero cells as an antigen (Schweizer et al., 1991) and was
found to cross-react with human CLIMP-63. Secondary antibodies were Alexa
Fluor 488 goat anti-mouse IgG2a, Alexa Fluor 568 goat anti-mouse IgG1,
Alexa Fluor 568 goat anti-mouse IgG3, Alexa Fluor 568 goat anti-rabbit
(Molecular Probes, Eugene, OR), and horseradish peroxidase- coupled goat
anti-mouse and goat anti-rabbit antibodies (Jackson ImmunoResearch Labo-
ratories, West Grove, PA).
Analysis of Mitotic Phosphorylation
HeLa cells of a 10-cm dish were incubated for 1 h in phosphate-free medium
and labeled for 3 h at 37°C with [32P]orthophosphate (carrier free in HCl
solution; Amersham Biosciences, Piscataway, NJ) (500 Ci/dish). Cells were
then washed twice with ice-cold PBS and harvested by scraping followed by
centrifugation for 10 min at 750 g at 4°C. Cell pellets were solubilized for 1 h
on ice in 100 mM Na2HPO4, pH 8.0, containing 1% Triton X-100 and protease
inhibitors as well as phosphatase inhibitor cocktails 1 and 2 (Sigma-Aldrich,
St. Louis, MO), and centrifuged for 1 h at 100,000  g at 4°C. Endogenous
CLIMP-63 and CLIMP-63 short constructs were affinity purified from the
supernatant on a column of mAb G1/296 coupled to protein A-Sepharose
CL-4B (Amersham Biosciences). After a 2-h incubation at 4°C, the resin was
washed 12 times with lysis buffer, proteins were eluted in Laemmli buffer,
and separated by 8% SDS-PAGE followed by autoradiography. For enrich-
ment in mitotic cells, 100 nM nocodazole was added 18 h before starvation.
Starvation and labeling steps were carried out in the presence of the drug, and
mitotic cells were harvested by rinsing the plate with medium. Aliquots of the
100,000  g supernatants were trichloroacetic acid precipitated and used to
determine total radioactivity by scintillation counting. Phosphorylation levels
of CLIMP-63 constructs were quantified by measuring signal intensity on a
STORM 840 PhosphorImager (Amersham Biosciences) by using the Image-
Quant software. Values were normalized referring to total incorporation of
radioactivity. Nocodazole-induced mitotic enrichment was monitored by
Western blotting of gels run with acid extracts of interphase and mitotic cells
and probed with an antibody against phosphorylated histone 3.
RESULTS
A Triple Phospho-mimicking Mutant and a Mutant
Impaired in Microtubule Binding of CLIMP-63 Induce ER
Clustering
In pilot experiments using metabolic labeling with
[32P]orthophosphate, we found that the cytoplasmic domain
of CLIMP-63 becomes phosphorylated in HeLa cells during
mitosis (our unpublished data; Figure 6). This finding raised
the possibility that CLIMP-63 may be phosphorylated at the
onset of mitosis for subsequent detachment of ER mem-
branes from the MT cytoskeleton. As shown in Figure 1, the
cytosolic tail of CLIMP-63 contains four consensus sites for
phosphorylation, three of which (Ser3, Ser19, and Ser101)
are protein kinase C (PKC) sites, whereas Ser17 is a casein
kinase II (CKII) site.
To test a potential role of the putative phosphorylation
sites, several phospho-mimicking mutants of CLIMP-63
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were made in which the serines were replaced by glutamic
acid, either individually or in combination (Table 1). The
mutants were transiently expressed in COS cells and ana-
lyzed by immunofluorescence confocal laser scanning mi-
croscopy. As a negative control for MT binding, we used
CLIMP-63, a construct lacking cytoplasmic amino acids
2–28 and 62–101 (Figure 1). CLIMP-63 was constructed in a
separate study aiming at the identification of the minimal
CLIMP-63 MT-binding domain (Klopfenstein and Hauri,
unpublished data; also see Results). It is unable to bind to
MTs in vitro and was chosen for the current study because
of its convenient expression in vivo, because more exten-
sively deleted constructs proved to be unstable.
The immunofluorescence pattern of CLIMP-63 was de-
scribed previously (Schweizer et al., 1993a,b; Klopfenstein et
al., 1998). Endogenous CLIMP-63 has a discrete punctate
pattern typical for the ER, except that the protein is excluded
from the nuclear envelope. By contrast, in CLIMP-63–over-
expressing cells, antibodies against CLIMP-63 label an ex-
tensively tubulated network. Additional experiments
showed this pattern to be the result of alignment of ER
membranes along bundled MTs. The ER rearrangement in-
duced by CLIMP-63 can be seen in 40% of the transfected
cells (Klopfenstein et al., 1998).
In the present study, we found that the MT-binding–
impaired CLIMP-63 induces another type of ER remodel-
ing. Cells transfected with CLIMP-63 indeed frequently
exhibit clustering of their ER around the nucleus, from
which a poorly reticulated network extends toward the cell
periphery (Figure 2, A and G). Double labeling experiments
with an antibody against BAP31, a major integral membrane
protein of the ER (Klumperman et al., 1998), confirmed that
this pattern reflects an overall redistribution of the ER (Fig-
ure 2B). Additional immunofluorescence experiments
showed that another ER marker, ERp72, colocalizes with
BAP31 and CLIMP-63 and that the same phenotype can be
induced in transiently transfected HeLa cells (our unpub-
lished data). Clustered ER was observed in 30–40% of the
expressing COS cells. We then analyzed the CLIMP-63 phos-
pho-mimicking mutants by using the same assay. Strikingly,
the quadruple mutant CLIMP-63 (S3E S17E S19E S101E) and
the triple mutant CLIMP-63 (S3E S17E S19E) also were able
to cluster the ER in a similar way to CLIMP-63 (in 20–30%
of the cells), although the reorganization of the ER was
somewhat less drastic (exemplified for the triple mutant in
Figure 2, D–F). ER clustering was not observed for any other
triple, double, or single phospho-mimicking mutant (Table
1), suggesting that the specific combination of the three
point mutations S3E, S17E, and S19E was required for gen-
erating ER clustering. Western blot analysis confirmed that
all mutant proteins were intact and expressed at similar
levels (our unpublished data).
To further characterize this new phenotype, we costained
cells expressing CLIMP-63, CLIMP-63 (S3E S17E S19E
S101E), or CLIMP-63 (S3E S17E S19E) for tubulin. In all
cases, cells having clustered ER exhibited a MT pattern that
is typical for unperturbed interphase cells (Figure 2, G–I; our
unpublished data). Thus, ER clustering is not a result of an
altered MT cytoskeleton. We also expressed a serine-to-
alanine control mutant, CLIMP-63 (S3A S17A S19A), in
which the crucial serines were replaced by alanines, thereby
preventing phosphorylation. This mutant was expected to
behave like wild-type (wt) CLIMP-63. Indeed, this mutant
colocalized with and bundled MTs (Figure 2, J–L). The
change included the entire ER, as confirmed by additional
double-labeling experiments with antibodies against BAP31
and CLIMP-63 or BAP31 and tubulin (our unpublished
data). The results demonstrate that CLIMP-63 (S3A S17A
S19A) behaves like wt CLIMP-63 (Klopfenstein et al., 1998).
It is important to note the difference in the MT pattern
induced by the triple phospho-mimicking mutant and the
triple alanine mutation. In the former case, the MT pattern
remains unchanged, whereas in the latter case the MT pat-
tern changes in parallel with the ER (Figure 2, compare I and
L). We conclude that the ER clustering induced by
CLIMP-63 (S3E S17E S19E S101E) and CLIMP-63 (S3E S17E
S19E) is specific to phospho-mimicking mutations.
CLIMP-63* Constructs Behave Like Their Full-Length
Counterparts
To distinguish CLIMP-63 mutants from the endogenous
protein in biochemical experiments, we slightly shortened
them. By using convenient restriction sites in pcDNA3-p63
constructs, we created CLIMP-63 proteins lacking the C-
terminal residues 538–602. These mutants are specified with
an asterisk (*). To test whether the small luminal deletion
Figure 1. Cytosolic tail sequences of CLIMP-63 (top lane) and
CLIMP-63 that is impaired in MT binding (bottom lane). Consen-
sus phosphorylation sites for PKC and CKII are indicated in bold
and underlined, respectively.
Table 1. Features of CLIMP-63 phospho-mimicking mutants
ER clustering MT cosedimentation






S3E S17E  nd
S3E S19E nd nd
S3E S101E  nd
S17E S19E  nd
S17E S101E  nd
S19 S101E nd nd
S3E S17E S19E a 
S3E S17E S101E  
S3E S19E S101E  
S17E S19E S101E  
S3E S17E S19E S101E a 
CLIMP-63 a 
, in vitro cosedimentation of the mutant with MTs, and ability and
efficiency to reorganize the ER in vivo. Nd, not determined.
a Corresponding shortened forms also cluster the ER.
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Figure 2. Overexpressed CLIMP-63 and CLIMP-63 (S3E S17E S19E) induce ER clustering. COS cells were transfected with CLIMP-63
(A–C and G–I), CLIMP-63 (S3E S17E S19E) (D–F), or CLIMP-63 (S3A S17A S19A) (J–L). Forty-eight hours posttransfection, the cells were fixed,
permeabilized, stained for CLIMP-63 (A, D, G, and J), BAP31 (B and E), or tubulin (H and K), and analyzed by immunofluorescence confocal
laser scanning microscopy. (C, F, I and L) Merged images. Transfected cells are indicated by an asterisk. Bar, 10 M.
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had an effect on the properties of the mutants, we expressed
the CLIMP-63* constructs in COS cells and localized them by
immunofluorescence microscopy by using three different
antibodies against CLIMP-63. mAb G1/296, an IgG2A,
(Schweizer et al., 1993a) was used in single-labeling experi-
ments where it clearly identified all transfected CLIMP-63*
constructs (our unpublished data). A rabbit antibody and
mAb A1/59 (an IgG1) against CLIMP-63 could be used in
double-labeling experiments with a mAb against BAP31 (an
IgG2A). Figure 3 shows that the shortened proteins induced
the expected phenotypes: tubular rearrangement of the ER
induced by CLIMP-63* (Figure 3, G–I) versus ER clustering
induced by CLIMP-63* (Figure 3, A–C). CLIMP-63* (S3E
S17E S19E) and CLIMP-63* (S3E S17E S19E S101E) also
maintained their ability to cluster the ER very much like
their full-length counterparts (our unpublished data).
CLIMP-63* constructs did not mislocalize to the cell surface
or the nuclear membrane (our unpublished data), unlike
more extensively deleted CLIMP-63 constructs (Schweizer et
al., 1994; Klopfenstein et al., 2001).
mAb A1/59 was unable to detect CLIMP-63* proteins.
Cells expressing CLIMP-63* or CLIMP-63* (as judged from
their tubulated or clustered ER, respectively) exhibited a
very weak immunofluorescence staining (Figure 3, D–F,
J–L). The staining was weaker than the A1/59 staining in
nontransfected cells, presumably because the nonreacting
transfected constructs mask the A1/59 epitope of the endog-
enous CLIMP-63. The inability of A1/59 mAb to recognize
CLIMP-63* constructs was confirmed by immunoprecipita-
tion experiments in which mAb A1/59 only immunoprecipi-
tated endogenous CLIMP-63 (Figure 4). Obviously, CLIMP-
63* constructs lack the A1/59 epitope. In contrast, mAb
G1/296 and the polyclonal anti-CLIMP-63 immunoprecipi-
tated the shortened proteins as efficiently as full-length
CLIMP-63.
Collectively, these results suggest that CLIMP-63* con-
structs behave like their full-length counterparts. They were
therefore considered suitable for the subsequent biochemical
experiments.
Endogenous CLIMP-63 of Mitotic Cells and CLIMP-63
Phospho-mimicking Mutants Fail to Bind to MTs
Our observations that overexpression of some phospho-
mimicking mutants induces the ER to collapse without al-
tering MT cytoskeleton in the same way as a mutant im-
paired in MT binding suggest that phosphorylation blocks
the interaction of CLIMP-63 with MTs. To directly test this
notion and its relevance for mitosis, we performed in vitro
MT-binding assays. We first studied the ability of endoge-
nous CLIMP-63 to bind to MTs in mitotic and interphase
cells. For this purpose, COS cells were either mitotically
arrested by nocodazole or left untreated (interphase cells).
Detergent extracts were incubated with taxol-stabilized
MTs, and CLIMP-63 binding to MTs was monitored by MT
cosedimentation. As shown in Figure 5, top left panels, a
significant amount of interphase CLIMP-63 bound to MTs as
described previously (Klopfenstein et al., 1998). In contrast,
CLIMP-63 extracted from mitotic cells was unable to bind to
MTs.
To study the effect of phosphorylation on the binding of
CLIMP-63 to MTs in vitro, we analyzed the phospho-mim-
icking mutants extracted from interphase COS cells that had
been transfected with the shortened forms of these mutants.
CLIMP-63* was used as a positive control and CLIMP-63*
as a negative control. CLIMP-63* did not show any binding
to MTs, identical to CLIMP-63 (our unpublished data),
whereas CLIMP-63* bound to MT with similar efficiency as
CLIMP-63 (Figure 5, top right). The ER clustering mutants
CLIMP-63* (S3E S17E S19E S101E) and CLIMP-63* (S3E S17E
S19E) also were unable to bind to MTs (Figure 5, bottom).
The three other phospho-mimicking triple mutants were
affected to various extents in their MT binding (Figure 5,
bottom; and summarized in Table 1). In the conditions we
used to visualize overexpressed mutants, endogenous
CLIMP-63 is sometimes barely visible. However, when de-
tected, it often seems to bind less efficiently to MTs in
transfected cells. Although 40–60% of the protein routinely
bind to MT in vitro (Klopfenstein et al., 1998) (Figure 5), this
percentage is lower in cells that express phospho-mimicking
mutants that are severely affected for MT binding. In con-
trast, binding of endogenous CLIMP-63 is unaltered in cells
overexpressing CLIMP-63* and CLIMP-63*. When probed
by coimmunoprecipitation experiments under conditions
used for MT-binding assay, shortened CLIMP-63 phospho-
mimicking mutants, but not CLIMP-63*, oligomerize with
endogenous CLIMP-63 (our unpublished data). Therefore,
the binding of endogenous CLIMP-63 is negatively affected
when cells coexpress a mutant that retains full oligomeriza-
tion capacity and binds less efficiently to MTs. These results
further argue that phospho-mimicking mutants are indeed
impaired for MT binding.
In conclusion, endogenous CLIMP-63 from mitotic cells is
unable to bind to MT in vitro, and the mimicking of phos-
phorylation on the serines 3, 17, and 19 is sufficient to
prevent CLIMP-63 from MT binding.
CLIMP-63 S3E S17E S19E Is Not Phosphorylated during
Mitosis
To analyze the phosphorylation state of CLIMP-63 during
the cell cycle, HeLa cell lines were established that stably
express CLIMP-63*, CLIMP-63* (S3E S17E S19E), or
CLIMP-63*. Several clones were obtained for each con-
struct, only in some of which few cells exhibited tubulated
or clustered ER (see Discussion). Instead, the ER in these cell
lines retained a reticular appearance as judged by immuno-
staining for CLIMP-63. The clones were treated with no-
codazole to arrest cells in mitosis or left nonsynchronized,
and then metabolically labeled with [32P]orthophosphate
followed by immunoprecipitation with mAb G1/296. These
experiments showed that endogenous CLIMP-63 was 32P
labeled to some extent in interphase cells, but that its level of
phosphorylation increased two- to threefold during mitosis
(Figure 6A, top band in all three panels). CLIMP-63* exhib-
ited a similar increased mitotic signal, indicating that the
C-terminal deletion does not interfere with CLIMP-63’s abil-
ity to undergo mitotic phosphorylation (Figure 6A, top). In
contrast, CLIMP-63* (S3E S17E S19E) did not exhibit in-
creased phosphorylation during mitosis, although it was
phosphorylated to some extent during interphase (Figure
6A, bottom). This result indicates that CLIMP-63* (S3E S17E
S19E) has lost its mitosis-responsive phosphorylation sites.
As a negative control, we used the cytosolic deleted con-
struct CLIMP-63* that does not contain any of the phos-
phorylation sites of interest. This protein was phosphory-
lated neither in interphase nor at mitosis (Figure 6A,
middle). To verify the mitotic state of the nocodazole-treated
cells, we analyzed the phosphorylation state of histone 3,
which is specifically phosphorylated at mitosis, by using a
phosphospecific antibody against serine 10. Figure 6B shows
such an analysis performed with cells stably expressing
CLIMP-63* (S3E S17E S19E). The mitotic phosphorylation of
histone 3 was apparent in nocodazole-treated cells but un-
detectable in untreated cells, validating our procedure to
isolate mitotic cells.
C. Vedrenne et al.
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Figure 3. Immunofluorescence analysis of CLIMP-63* constructs. COS cells were transfected with CLIMP-63* (A–F) or CLIMP-63* (G–L)
and double stained for BAP31 (B, E, H, and K) and CLIMP-63, by using rabbit pc antibody (A and G) or mAb A1/59 (D and J). Transfected
cells are indicated by an asterisk. Bar, 10 M.
CLIMP-63 Controls ER/Microtubule Interaction
Vol. 16, April 2005 1933
DISCUSSION
Cell Cycle-dependent Phosphorylation of CLIMP-63
Because phosphorylation is known to regulate in many cases
the interaction between MTs and their associated proteins,
we studied the in vivo phosphorylation state of CLIMP-63.
Our results show that CLIMP-63 is already phosphorylated
to some extent during interphase but undergoes increased
phosphorylation during mitosis. The phosphorylation signal
of CLIMP-63 detected in interphase cells may originate from
some mitotic cells present in the nonsynchronized cell pop-
ulation. Alternatively, CLIMP-63 may be a phosphoprotein
during interphase and undergo further phosphorylation
during mitosis. This seems possible because, apart from the
four putative sites for known kinases we have investigated,
the cytosolic tail of CLIMP-63 contains another 13 serine
residues. In support of CLIMP-63 phosphorylation during
interphase, we were unable to detect any phosphate-labeled
CLIMP-63* in interphase cells. In this construct, none of the
additional serine residues is present (Figure 1). This finding
is consistent with some constitutive phosphorylation on one
or more of the additional serine residues during interphase.
Interphase phosphorylation may reflect local detachment
of CLIMP-63 from ER membranes. While maintaining its
characteristic steady-state structure, the ER undergoes con-
stant small-scale rearrangements that are likely mediated by
molecular motors (Lee and Chen, 1988; Waterman-Storer
and Salmon, 1998). Several publications have shown that
MAPs compete with motors for MT binding or exert a steric
blocking effect on motor-based movement (Bulinski et al.,
1997; Ebneth et al., 1998; Trinczek et al., 1999). It has been
proposed that MAP phosphorylation is required to facilitate
MT-based transport (Lopez and Sheetz, 1995; Sato-Harada et
al., 1996). In a similar way, it is conceivable that a subset of
CLIMP-63 is phosphorylated on additional serine residues
during interphase to allow local rearrangement of ER mem-
branes.
Figure 4. Analysis of CLIMP-63* (S3E S17E S19E) and CLIMP-63*
by immunoprecipitation. The mutants were expressed in COS cells,
immunoprecipitated with mAb G1/296 (G1), mAb A1/59 (A1), or
rabbit pc (pc), and analyzed by SDS-PAGE and Western blotting by
using mAb G1/296. #, antibody heavy chain.
Figure 5. Binding of endogenous CLIMP-63 and CLIMP-63* constructs to polymerized MTs in vitro. Endogenous CLIMP-63 of interphase
or mitotic COS cells, as well as CLIMP-63* proteins from COS transfected cells, were incubated either in the presence () of MTs (to test their
binding) or in absence () of MTs (autoprecipitation control). MTs were sedimented by centrifugation, and supernatant and pellet fractions
were analyzed by SDS-PAGE. Western blots were probed for CLIMP-63 (top) and tubulin (bottom). arrow, CLIMP-63* proteins; e,
endogenous CLIMP-63; p, pellet; s, supernatant; tub, tubulin.
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Mitosis-specific Phosphorylation of CLIMP-63
Our systematic analysis of CLIMP-63 phospho-mimicking
mutants revealed that CLIMP-63 (S3E S17E S19E S101E) and
CLIMP-63 (S3E S17E S19E) but not other mutants can rear-
range the ER in a way similar to the MT-binding–impaired
CLIMP-63 and are unable to bind to MTs in vitro. More-
over, mutating serine residues 3, 17, and 19 abolishes com-
pletely the mitosis-specific phosphorylation of CLIMP-63.
These results suggest that CLIMP-63 is detached from MTs
upon phosphorylation of serine residues 3, 17, and 19 during
mitosis.
A negative effect of protein phosphorylation on MT affin-
ity has been studied in detail for stabilizing MAPs, but little
is known concerning cytoskeleton linkers. Although phos-
phorylation mediates dynamic binding to MTs in the case of
CLIP-170 (Rickard and Kreis, 1991; Choi et al., 2002) and
CLIP-115 (Hoogenraad et al., 2000), this effect has not been
related to a cellular function. In the case of the dynactin
subunit p150Glued that shares a common MT binding domain
with CLIPs, phosphorylation-mediated release from MTs
was proposed to be a required step to initiate dynein-based
movement (Vaughan et al., 2002). With CLIMP-63, we have
now studied a membrane-anchored cytoskeleton linker pro-
tein and found that phosphorylation also is involved in
detachment from MTs, supporting the notion that this post-
translational modification is a general mechanism in regu-
lating MAP/MT interaction. Three phosphorylation events
are required to detach CLIMP-63 from MTs. Because the
resulting modifications are clustered near the N terminus of
the protein they can be expected to considerably change the
charge of this domain and thereby modify the interaction of
CLIMP-63 with MTs. It also is possible that a change in
protein shape is involved in this process, because phosphor-
ylation on Ser/Thr-Promotifs (S17 is followed by a proline)
is believed to affect the cis/trans isomerization properties of
the proline residue (Ramelot and Nicholson, 2001).
The serine residues we have identified in CLIMP-63 as
targets for mitotic phosphorylation belong to consensus sites
for PKC (S3 and S19) and CKII (S17). To our knowledge the
involvement of these kinases in the cell division process is
poorly documented. For example, a CKII-like kinase has
been proposed to be necessary for p115-mediated Golgi
reassembly of mitotic fragments (Dirac-Svejstrup et al.,
2000). Regarding structural MAPs, cyclin-dependent kinases
and mitogen activated protein kinases are responsible for
their mitotic phosphorylation (Shiina et al., 1992; Ookata et
al., 1997; Illenberger et al., 1998; Jiang et al., 1998; Shiina and
Tsukita, 1999; Cassimeris, 2002). In related studies, cAMP-
dependent protein kinase has been proposed to actively
participate in tau release from MTs during mitosis when this
neuronal MAP is expressed in Chinese hamster ovary cells
(Illenberger et al., 1998), and it is interesting to note that the
same pathway has been suggested to facilitate organelle
transport when tau is expressed in COS cells (Sato-Harada et
al., 1996). Whether PKC and CKII mediate the mitosis-spe-
cific phosphorylation of CLIMP-63 remains to be shown. We
can also not exclude that an unknown cell cycle-dependent
kinase is involved, because MAP-specific kinases also exist
(Drewes et al., 1995; Ebneth et al., 1999).
CLIMP-63 Binding to Microtubules and ER Morphology
The interdependence of MT and ER networks in mammalian
cells has been extensively described (Terasaki et al., 1986; Lee
et al., 1989; Cole and Lippincott-Schwartz, 1995). From a
mechanistic point of view, it is known that tubules extend-
ing from the ER in living migrating cells are formed by two
main processes: 1) motor-dependent membrane sliding
along preexisting MTs and 2) MT growing tip attachment
(Waterman-Storer and Salmon, 1998). These data support a
model in which the ER network forms by membrane exten-
sion toward the plus end of MTs. The importance of such a
transport also has been shown in several other studies,
where kinesin-dependent inhibition of transport, either by
antisense suppression of kinesin heavy chain (Feiguin et al.,
1994) or by overexpressing tau (Ebneth et al., 1998), led to the
retraction of the ER to the cell center. This phenotype is very
reminiscent of what we observe when overexpressing
CLIMP-63 mutants that fail to bind to MTs: ER membranes
no longer extend into the cell periphery and the number of
three-way junctions is considerably reduced. Our results
Figure 6. Mitotic phosphorylation of CLIMP-63. (A) Endogenous
wt CLIMP-63 and CLIMP-63* mutants were affinity purified from
35S-labeled interphase cells (35S) and 32P-labeled interphase (int) or
mitotic (mit) cells. After separation by 8% SDS-PAGE, radioactive
proteins were visualized by autoradiography. Phosphorylation lev-
els of endogenous CLIMP-63 and of CLIMP-63* constructs were
quantified. Mitotic phosphorylation is indicated at the right margin
of each panel as percentage of the interphase level of phosphoryla-
tion. Values for the CLIMP-63* and CLIMP-63* (S3E S17E S19E)
panels are means  SD (n  3). The value for the endogenous
protein in the CLIMP-63* panel is the mean of two values differing
by 19%. (B) Control for mitotic phosphorylation. Acid extracts of
untreated and nocodazole-treated cells expressing CLIMP-63* (S3E
S17E S19E) were separated by 12% SDS-PAGE. Western blots were
probed for serine 10-phosphorylated histone 3. Molecular weights
are indicated at the right margin. arrow, CLIMP-63* proteins; ar-
rowhead, no phosphorylation signal; #, background band; e, endog-
enous wt CLIMP-63.
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strongly suggest that, in addition to plus end-directed active
transport, a stable anchoring of membranes to MTs also is
required to establish the characteristic ER organization. We
propose that molecular motors pull membranes along MTs,
whereas nonmotile linkers, such as CLIMP-63, stabilize the
tubulated membrane processes. Interfering with either of
these processes would lead to ER retraction either due to
tension (Upadhyaya and Sheetz, 2004) or unmasking of the
slow retrograde flow of membrane-bound MTs that contin-
uously occurs within the cells (Terasaki and Reese, 1994;
Waterman-Storer and Salmon, 1997, 1998), leading to ER
retraction. Our experiments showed that some poorly
branched tubules almost always emerge from the ER con-
centrated in the perinuclear area. These processes may be
due to the presence of endogenous wt CLIMP-63. Alterna-
tively, they may represent tubules formed by attachment to
MT growing tips or by a proposed intrinsic ER membranes
property to reticulate (Dreier and Rapoport, 2000).
A collapse of the ER was observed in transiently trans-
fected cells but was almost absent from HeLa cells stably
expressing CLIMP-63* or CLIMP-63* (S3E S17E S19E).
Likewise, the tubulated phenotype was absent in cells stably
expressing CLIMP-63*. This discrepancy is consistent with
the view that a reticular characteristic of the ER is essential
for cell viability.
CLIMP-63 or homologous proteins are absent from yeast,
in which the ER is much simpler organized into perinuclear
ER and cortical ER underlying the plasma membrane. Yeast
ER mainly relies on the actin cytoskeleton for its dynamics
and maintenance (Prinz et al., 2000; Estrada et al., 2003). In
contrast, cells of higher eukaryotes with their complex retic-
ular ER largely rely on MTs and various mechanisms to
allow for membrane dynamics while maintaining the overall
structure of the ER. Our study presents CLIMP-63 as a novel
player in maintaining the ER as an extended polygonal
network and more generally highlights the necessity for a
synergistic action of motor- and nonmotor-dependent inter-
actions between MTs and membrane in this process.
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